RxDoctor Payments Data

Rameen Moridzadeh, MD

Vascular Surgery · West Hollywood, CANPI 1427445675

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.5%), other and travel and lodging — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Medtronic at 26.8% of the total. 2025 is the largest year on record at $9,441, more than ten times the $766 reported in 2019.

$22,605in general payments, 2019–2025

Across 205 payments — averaging $110.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Angiodynamics, Inc.$5K
  • Abbott$4K
  • W. L. Gore & Associates, Inc.$1K
  • Cook Medical LLC$1K
  • Endologix LLC$718
  • plus $5K from 35 others

What the payments were for

  • Speaking & faculty fees$3,20014%
  • Grants$1671%
  • Travel & lodging$3,32515%
  • Food & beverage$10,96449%
  • Other$4,95022%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,605 in reported general payments places this provider in the 85th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California →

Medicare billing

Part B allowed, 2024
$2,796,646
Medicare patients
1,805
Services billed
5,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$24,539
ClopidogrelClopidogrel Bisulfate35$216

Paid to pharmacies, not to this prescriber.

Other vascular surgery in West Hollywood

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →